PatientsVille.com Logo

Erythrocin Side Effects

PatientsVille

Common Erythrocin Side Effects


The most commonly reported Erythrocin side effects (click to view or check a box to report):

Pyrexia (7)
Vision Blurred (5)
Rash (5)
Nausea (5)
Abdominal Pain (5)
Chest Pain (5)
Condition Aggravated (4)
Renal Failure Acute (4)
Eyelid Oedema (4)
Diarrhoea (3)
Deafness (3)
Alanine Aminotransferase Increased (3)
Dyspnoea (3)
Platelet Count Decreased (3)
Eye Irritation (3)
Pancreatitis Acute (3)
Multi-organ Failure (3)
Lip Haemorrhage (2)
Muscle Twitching (2)
Malaise (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Erythrocin Side Effects Reported to FDA



Erythrocin Side Effect Report#9981173
Leukocytosis
This is a report of a 64-year-old male patient (weight: NA) from FR, suffering from the following health symptoms/conditions: NA, who was treated with Erythrocine /00020901/ (erythrocine) (not Specified) (dosage: (1 G 1x/3 Days Intravenous (not Otherwise Specified)), start time:
Sep 19, 2009), combined with:
  • Cordarone (cordarone - Amiodarone) (not Specified) ((df Intravenous (not Otherwise Specified)))
  • Cefotaxime Sodium (cefotaxime Sodium) ((df Intravenous (not Otherwise Specified)))
  • Lasilix /00032601/ (lasilix - Furosemide) (not Specified) ((df Intravenous (not Otherwise Specified)))
  • Tazocilline (tazocilline - Tazobactam) (not Specified) ((df))
  • Cefotaxime
  • Cefepime
and developed a serious reaction and side effect(s): Leukocytosis after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Erythrocine /00020901/ (erythrocine) (not Specified) treatment in male patients, resulting in Leukocytosis side effect. The patient was hospitalized.
Erythrocin Side Effect Report#9908077
Interstitial Lung Disease, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Gamma-glutamyltransferase Decreased
This report suggests a potential Erythrocin Interstitial Lung Disease side effect(s) that can have serious consequences. A 97-year-old male patient (weight: NA) from JP was diagnosed with the following symptoms/conditions: NA and used Erythrocin (dosage: NA) starting
Oct 31, 2013. After starting Erythrocin the patient began experiencing various side effects, including: Interstitial Lung Disease, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Gamma-glutamyltransferase DecreasedAdditional drugs used concurrently:
  • Bayaspirin
  • Ebastel
  • Theodur
  • Takepron
  • Carbocisteine Lysine
  • Ambroxol Hydrochloride
  • Levothyroxine Sodium
  • Sennoside /00571901/
Although Erythrocin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Interstitial Lung Disease, may still occur.
Erythrocin Side Effect Report#9386747
Injection Site Vasculitis
This Injection Site Vasculitis problem was reported by a pharmacist from JP. A 81-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: brain abscess. On
Jun 15, 2013 this consumer started treatment with Erythrocin Lactobionate (dosage: [1 Vial Dissolved W/ 10ml Water For Injection,diluted With 100 Ml Saline, Administered Over 2 Hours). The following drugs were being taken at the same time:
  • Meropenem Trihydrate
When using Erythrocin Lactobionate, the patient experienced the following unwanted symptoms/side effects: Injection Site VasculitisAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Injection Site Vasculitis, may become evident only after a product is in use by the general population.
Erythrocin Side Effect Report#9274875
Deafness
This Deafness side effect was reported by a consumer or non-health professional from JP. A female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Erythrocin (drug dosage: NA), which was initiated on 201208. Concurrently used drugs:
  • Biological Preparations
  • Cimetidine
.After starting to take Erythrocin the consumer reported adverse symptoms, such as: DeafnessThese side effects may potentially be related to Erythrocin.
Erythrocin Side Effect Report#9168682
Thrombocytopenia
This is a report of a 65-year-old female patient (weight: NA) from JP, suffering from the following health symptoms/conditions: postoperative wound infection, who was treated with Erythrocin (dosage: NA, start time:
Jan 27, 2013), combined with:
  • Targocid
  • Rifampicin
  • Warfarin Potassium
  • Aspirin
  • Magnesium Oxide
and developed a serious reaction and side effect(s): Thrombocytopenia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Erythrocin treatment in female patients, resulting in Thrombocytopenia side effect. The patient was hospitalized.
Erythrocin Side Effect Report#8974193
Pulmonary Sarcoidosis, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Lymphocyte Stimulation Test Positive, Granuloma, Necrosis, Eczema, Sarcoidosis
This report suggests a potential Erythrocin Pulmonary Sarcoidosis side effect(s) that can have serious consequences. A 26-year-old female patient (weight: NA) from JP was diagnosed with the following symptoms/conditions: diffuse panbronchiolitis and used Erythrocin (dosage: (df)) starting 2010. After starting Erythrocin the patient began experiencing various side effects, including: Pulmonary Sarcoidosis, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Lymphocyte Stimulation Test Positive, Granuloma, Necrosis, Eczema, SarcoidosisAdditional drugs used concurrently:
  • Klaricid ((df))
  • Clarithromycin (clarithromycin) ((df))
  • Loxoprofen Sodium ((df))
  • Loxonin
The patient was hospitalized. Although Erythrocin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pulmonary Sarcoidosis, may still occur.
Erythrocin Side Effect Report#8962318
Hepatitis, Renal Failure Acute, Duodenal Fistula, Toxic Skin Eruption
This Hepatitis problem was reported by a health professional from FR. A 77-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: antibiotic prophylaxis. On
Jul 13, 2012 this consumer started treatment with Erythrocin (dosage: NA). The following drugs were being taken at the same time:
  • Tazocilline
  • Tienam
  • Tienam
  • Amikacin
  • Vancomycine Merck
When using Erythrocin, the patient experienced the following unwanted symptoms/side effects: Hepatitis, Renal Failure Acute, Duodenal Fistula, Toxic Skin EruptionThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Hepatitis, may become evident only after a product is in use by the general population.
Erythrocin Side Effect Report#8923195
Erythema, Hepatitis, Renal Failure Acute, Pyrexia, Eosinophilia
This Erythema side effect was reported by a health professional from FR. A 77-year-old male patient (weight:NA) experienced the following symptoms/conditions: antibiotic prophylaxis.The patient was prescribed Erythrocin (drug dosage: NA), which was initiated on
Jul 13, 2012. Concurrently used drugs:
  • Tazocilline
  • Tienam
  • Amikacine Merck
  • Vancomycine Merck
.After starting to take Erythrocin the consumer reported adverse symptoms, such as: Erythema, Hepatitis, Renal Failure Acute, Pyrexia, EosinophiliaThese side effects may potentially be related to Erythrocin. The patient was hospitalized.
Erythrocin Side Effect Report#8902279
Neutropenia, Lymphopenia
This is a report of a 69-year-old female patient (weight: NA) from FR, suffering from the following health symptoms/conditions: NA, who was treated with Erythrocin (dosage: NA, start time:
Sep 18, 2012), combined with:
  • Rocephine
  • Ofloxacine
  • Glucophage
  • Daonil
  • Fractal
and developed a serious reaction and side effect(s): Neutropenia, Lymphopenia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Erythrocin treatment in female patients, resulting in Neutropenia side effect. The patient was hospitalized.
Erythrocin Side Effect Report#8833777
Hepatocellular Injury, Hepatomegaly, Liver Injury, Pyrexia, Jaundice
This report suggests a potential Erythrocine Hepatocellular Injury side effect(s) that can have serious consequences. A 11-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: pertussis and used Erythrocine (dosage: (df Oral)) starting
Aug 24, 2012. After starting Erythrocine the patient began experiencing various side effects, including: Hepatocellular Injury, Hepatomegaly, Liver Injury, Pyrexia, JaundiceAdditional drugs used concurrently: NA.The patient was hospitalized. Although Erythrocine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Hepatocellular Injury, may still occur.
Erythrocin Side Effect Report#8791264
Cholestasis, Gamma-glutamyltransferase Increased, Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased
This Cholestasis problem was reported by a health professional from FR. A 53-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: gastrointestinal motility disorder. On
Jul 03, 2012 this consumer started treatment with Erythrocine (dosage: NA). The following drugs were being taken at the same time:
  • Inexium
  • Vitamin B1
  • Imovane
  • Oliclinomel
When using Erythrocine, the patient experienced the following unwanted symptoms/side effects: Cholestasis, Gamma-glutamyltransferase Increased, Alanine Aminotransferase Increased, Blood Alkaline Phosphatase IncreasedAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Cholestasis, may become evident only after a product is in use by the general population.
Erythrocin Side Effect Report#8560902
Bradycardia, Blood Pressure Decreased, Epilepsy
This Bradycardia side effect was reported by a health professional from JP. A 7-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Erythrocin W (erythromycin Ethylsuccinate) (drug dosage: NA), which was initiated on
Apr 09, 2012. Concurrently used drugs:
  • Depakene (valproic Acid)
  • Procaterol (procaterol)
  • Theophylline (theophylline)
  • Lioresal (baclofen)
  • Etizolam (etizolam)
  • Eurodin (dihydroergocristine Mesilate)
  • Pantethine (pantethine)
  • Qvar (beclometasone Dipropionate)
.After starting to take Erythrocin W (erythromycin Ethylsuccinate) the consumer reported adverse symptoms, such as: Bradycardia, Blood Pressure Decreased, EpilepsyThese side effects may potentially be related to Erythrocin W (erythromycin Ethylsuccinate).
Erythrocin Side Effect Report#8345575-5
Condition Aggravated, Eyelid Irritation
This is a report of a 91-year-old female patient (weight: NA) from United States, suffering from the following health symptoms/conditions: eyelid infection, who was treated with Erythrocin 1% (dosage: NA, start time:
Feb 17, 2012), combined with:
  • Alrex
  • Multivitamin
and developed a serious reaction and side effect(s): Condition Aggravated, Eyelid Irritation after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Erythrocin 1% treatment in female patients, resulting in Condition Aggravated side effect.
Erythrocin Side Effect Report#8098339-4
Interstitial Lung Disease
This report suggests a potential Erythrocin Lactobionate Interstitial Lung Disease side effect(s) that can have serious consequences. A 72-year-old male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: NA and used Erythrocin Lactobionate (dosage: NA) starting
May 11, 2009. After starting Erythrocin Lactobionate the patient began experiencing various side effects, including: Interstitial Lung DiseaseAdditional drugs used concurrently:
  • Levoleucovorin Calcium
  • Levoleucovorin Calcium
  • Warfarin Sodium
  • Magmitt
  • Minocycline Hcl
  • Erbitux
  • Fluorouracil
  • Fluorouracil
The patient was hospitalized. Although Erythrocin Lactobionate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Interstitial Lung Disease, may still occur.
Erythrocin Side Effect Report#7979117-0
Pain, Vein Wall Hypertrophy, Anxiety, Anhedonia, Deep Vein Thrombosis, Deformity
This Pain problem was reported by a consumer or non-health professional from China. A 19-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Jan 01, 2004 this consumer started treatment with Erythrocin Lactobionate (dosage: Unk). The following drugs were being taken at the same time:
  • Zyrtec
  • Diosmin (25 Mg, Bid)
  • Yaz (Unk)
  • Zithromax
  • Differin (0.1 %, Prn)
  • Synthroid (Unk)
When using Erythrocin Lactobionate, the patient experienced the following unwanted symptoms/side effects: Pain, Vein Wall Hypertrophy, Anxiety, Anhedonia, Deep Vein Thrombosis, DeformityThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Pain, may become evident only after a product is in use by the general population.
Erythrocin Side Effect Report#7954801-3
Deafness
This Deafness side effect was reported by a physician from Japan. A female patient (weight:NA) experienced the following symptoms/conditions: mediastinal abscess,lung abscess,sepsis.The patient was prescribed Erythrocin Lactobionate (drug dosage: NA), which was initiated on
Nov 02, 2010. Concurrently used drugs:
  • Amikacin Sulfate
  • Amikacin Sulfate
  • Amikacin Sulfate
  • Imipenem And Cilastatin Sodium
  • Imipenem And Cilastatin Sodium
  • Carbimazol
.After starting to take Erythrocin Lactobionate the consumer reported adverse symptoms, such as: DeafnessThese side effects may potentially be related to Erythrocin Lactobionate.
Erythrocin Side Effect Report#7872185-6
Disseminated Intravascular Coagulation, Pancreatitis Acute
This is a report of a 6-year-old female patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Erythrocin (dosage: (1 Gm) Oral), start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Disseminated Intravascular Coagulation, Pancreatitis Acute after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Erythrocin treatment in female patients, resulting in Disseminated Intravascular Coagulation side effect.
Erythrocin Side Effect Report#7789422-9
Embolic Stroke, Cardiac Failure Congestive, Activated Partial Thromboplastin Time Prolonged
This report suggests a potential Erythrocin Lactobionate Embolic Stroke side effect(s) that can have serious consequences. A male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: bronchiectasis and used Erythrocin Lactobionate (dosage: 600 Mg) starting
Jul 13, 2011. After starting Erythrocin Lactobionate the patient began experiencing various side effects, including: Embolic Stroke, Cardiac Failure Congestive, Activated Partial Thromboplastin Time ProlongedAdditional drugs used concurrently:
  • Cleanal (1200 Mg)
  • Pradaxa (220 Mg)
  • Zolpidem
  • Gamofa (40 Mg)
The patient was hospitalized. Although Erythrocin Lactobionate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Embolic Stroke, may still occur.
Erythrocin Side Effect Report#7763088-6
Diplopia, Vision Blurred
This Diplopia problem was reported by a consumer or non-health professional from United States. A 62-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: eyelid infection. On
Jul 19, 2010 this consumer started treatment with Erythrocin 1% (dosage: NA). The following drugs were being taken at the same time: NA. When using Erythrocin 1%, the patient experienced the following unwanted symptoms/side effects: Diplopia, Vision BlurredAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Diplopia, may become evident only after a product is in use by the general population.
Erythrocin Side Effect Report#7755524-6
Depressed Level Of Consciousness, Arrhythmia, Chest Pain, Cor Pulmonale, Ventricular Tachycardia, Respiratory Arrest
This Depressed Level Of Consciousness side effect was reported by a health professional from Japan. A female patient (weight:NA) experienced the following symptoms/conditions: bronchiolitis.The patient was prescribed Erythrocin (drug dosage: 600 Mg, (200 , 3 In 1 D) Oral), which was initiated on
Jun 30, 2006. Concurrently used drugs:
  • Pimobendam
  • Theophylline
  • Tiotropium Bromide Monohdrate
  • Dospyramide
  • Furosemide
  • Rabeprazole Sodium
  • Ursodiol
  • Clarithromycin (200 Mg, (1 In 1 D) Oral, (800 Mg, 800mg (400 Mg, 2 In 1 D) Oral)
.After starting to take Erythrocin the consumer reported adverse symptoms, such as: Depressed Level Of Consciousness, Arrhythmia, Chest Pain, Cor Pulmonale, Ventricular Tachycardia, Respiratory ArrestThese side effects may potentially be related to Erythrocin.
Erythrocin Side Effect Report#7716397-0
Hypoglycaemia, Renal Failure Acute, Hyperkalaemia, Pneumocystis Jiroveci Pneumonia, Altered State Of Consciousness
This is a report of a 60-year-old male patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Erythrocin Lactobionate (dosage: NA, start time:
Jan 01, 2011), combined with:
  • Pyridoxal Phosphate
  • Fluticasone Propionate
  • Januvia
  • Isoniazid
  • Ganciclovir
  • Pentamidine Isethionate
  • Hokunalin
  • Amaryl
and developed a serious reaction and side effect(s): Hypoglycaemia, Renal Failure Acute, Hyperkalaemia, Pneumocystis Jiroveci Pneumonia, Altered State Of Consciousness after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Erythrocin Lactobionate treatment in male patients, resulting in Hypoglycaemia side effect. The patient was hospitalized.
Erythrocin Side Effect Report#7608199-0
Oculomucocutaneous Syndrome, Stevens-johnson Syndrome
This report suggests a potential Erythrocin Oculomucocutaneous Syndrome side effect(s) that can have serious consequences. A 30-year-old female patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: NA and used Erythrocin (dosage: (200 Mg)) starting
Jan 01, 2009. After starting Erythrocin the patient began experiencing various side effects, including: Oculomucocutaneous Syndrome, Stevens-johnson SyndromeAdditional drugs used concurrently: NA. Although Erythrocin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Oculomucocutaneous Syndrome, may still occur.
Erythrocin Side Effect Report#7250346-7
Platelet Count Decreased
This Platelet Count Decreased problem was reported by a pharmacist from Japan. A 81-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Erythrocin Lactobionate (dosage: 500 Mg, 2x/day). The following drugs were being taken at the same time:
  • Solu-medrol (500 Mg, 2x/day)
  • Amlodipine (5 Mg, 1x/day)
  • Lasix (20 Mg, 1x/day)
  • Unasyn (1.5 Mg, 2x/day)
  • Glyburide (1.25 Mg, 1x/day)
  • Paxil (Unk)
When using Erythrocin Lactobionate, the patient experienced the following unwanted symptoms/side effects: Platelet Count DecreasedAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Platelet Count Decreased, may become evident only after a product is in use by the general population.
Erythrocin Side Effect Report#7145718-5
Nausea
This Nausea side effect was reported by a consumer or non-health professional from United States. A female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Erythrocin Lactobionate (drug dosage: NA), which was initiated on
Apr 15, 2010. Concurrently used drugs:
  • Synthroid
  • Crestor
  • Mvt
  • Calcium
  • Vitamin D
  • Fish Oil
.After starting to take Erythrocin Lactobionate the consumer reported adverse symptoms, such as: NauseaThese side effects may potentially be related to Erythrocin Lactobionate.
Erythrocin Side Effect Report#7048378-7
Dyspnoea
This is a report of a 45-year-old male patient (weight: NA) from United Kingdom, suffering from the following health symptoms/conditions: NA, who was treated with Erythrocin Es 500 Mg Tablets (dosage: NA, start time:
Sep 30, 2010), combined with: NA. and developed a serious reaction and side effect(s): Dyspnoea after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Erythrocin Es 500 Mg Tablets treatment in male patients, resulting in Dyspnoea side effect.


1 of 4 


The appearance of Erythrocin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.


What are common Erythrocin Side Effects for Women?

Women Side EffectsReports
Abdominal Pain 5
Chest Pain 5
Nausea 5
Pyrexia 5
Condition Aggravated 4
Eyelid Oedema 4
Deafness 3
Rash 3
Vision Blurred 3
Agitation 2

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Erythrocin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Erythrocin Side Effects

    Did You Have a Erythrocin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Erythrocin for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Erythrocin Safety Alerts, Active Ingredients, Usage Information

    NDC0074-6316
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameErythrocin Stearate
    NameErythromycin Stearate
    Dosage FormTABLET, FILM COATED
    RouteORAL
    On market since19640624
    LabelerAbbVie Inc.
    Active Ingredient(s)ERYTHROMYCIN STEARATE
    Strength(s)500
    Unit(s)mg/1
    Pharma ClassDecreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Ch

    More About Erythrocin

    Side Effects reported to FDA: 88

    Erythrocin safety alerts: No

    Reported deaths: 9

    Reported hospitalizations: 20

    Latest Erythrocin clinical trials

    Erythrocin Reviews

    No reviews, be a first to report a side effect via side effect reporting form